KCNA3 and B-cell chronic lymphocytic leukemia: Here we show that Kv1.3 expression in human primary CLL B cells correlates with sensitivity of the neoplastic cells to the mitochondria-targeted inhibitor PAPTP (1 μM) that acts on the mitochondrial counterpart of Kv1.3 (Fig. 1a).